Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Ionis completes enrollment in pivotal cohort of the Phase 3 REVEAL study evaluating obudanersen in Angelman syndrome

Summary by Carroll County Mirror-Democrat
Topline data from REVEAL anticipated in 2H 2027

6 Articles

The Norfolk Daily NewsThe Norfolk Daily News
+4 Reposted by 4 other sources
Center

Ionis completes enrollment in pivotal cohort of the Phase 3 REVEAL study evaluating obudanersen in Angelman syndrome

Topline data from REVEAL anticipated in 2H 2027

Read Full Article
Verdict HospitalVerdict Hospital

Ionis Pharmaceuticals concludes REVEAL study pivotal cohort enrolment

Ionis Pharmaceuticals has concluded enrolment in the pivotal cohort of its Phase III REVEAL study of obudanersen as an investigational RNA-targeted medicine for AS.The post Ionis Pharmaceuticals concludes REVEAL study pivotal cohort enrolment appeared first on Hospital Management.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources are Center
67% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Carroll County Mirror-Democrat broke the news in Mount Carroll, United States on Monday, July 6, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Carlsbad, California icon

Carlsbad, California

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal